Medibank Private stock
Price history
+9.77% over the period1 year: from $4.81 (November 18, 2025) to $5.28 (November 18, 2026), +9.77%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 18, 2026 | $5.28 |
| October 30, 2026 | $5.09 |
| September 30, 2026 | $4.62 |
| August 31, 2026 | $4.84 |
| July 31, 2026 | $5.17 |
| June 30, 2026 | $4.97 |
| May 29, 2026 | $4.80 |
| April 30, 2026 | $4.69 |
| March 31, 2026 | $4.36 |
| February 27, 2026 | $4.38 |
| January 30, 2026 | $4.62 |
| December 31, 2025 | $4.79 |
| November 28, 2025 | $4.75 |
| November 18, 2025 | $4.81 |
At a glance
The company
Provides private health insurance and health management services in Australia under the Medibank and ahm brands
Latest results
Quarter to June 30, 2026 · EPS $0.12 (estimate $0.10)
TickerLandia's take on Medibank Private
- Priced as usual relative to earnings: P/E on the latest fiscal year 23 vs a median of 22 over its last 10 fiscal years.
- Pricier than similar companies: trailing 12-month P/E 23 vs 18 (+29%) in a group of 11.
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−3.47% from the 52-week high
Analysts · 9 analysts
Average target$5.06−4.25% vs. price
Buy 2 · Hold 7 · Sell 0 · Hold
TickerLandia Fingerprint: Medibank Private
Compared with similar companies: very low risk and very high price.
Financials and price compared with 114 companies in related industries (insurance), worldwide. Momentum and risk compared with 1,069 Asia-Pacific stocks.
Pricevery high83
How much it costs relative to what it produces.
Metric Value Position in group Price/book 6.12 92 Price/sales 1.60 60 P/E (trailing 12 months) 23.5 87 Forward P/E 20.0 92 Profitabilityaverage60
How much it earns on revenue and capital.
Metric Value Position in group Operating margin 10.3% 25 ROA 12.6% 96 Net margin 6.9% 29 ROE 27.2% 89 Earnings stabilityhigh66
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 1.6% 73 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 59 Growthhigh71
How fast revenue and earnings are growing.
Metric Value Position in group Average revenue growth (3 years) +7.91% 44 Revenue growth (year over year) +12.60% 76 Earnings growth (year over year) +109.90% 93 Financial strengthdoes not apply to banks and insurers
How well it would weather a hard period: debt, liquidity, interest.
Dividendaverage56
How much it returns to shareholders, and for how long.
Metric Value Position in group Dividend yield 3.5% 55 Consecutive dividend years at least 12 years 28 Payout ratio 83.5% 85 Market momentumstrong65
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) +7.39% 62 Relative strength (6 months) +7.79% 63 1-year return +9.77% 55 Distance from 200-day average +10.96% 82 Riskvery low10
How much the price swings.
Metric Value Position in group Maximum drawdown (12 months) 15.6% 7 Volatility (60 days) 19.4% 6 Beta (1 year) 0.22 17
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 18, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Medibank Private is priced as in the past and pricier than similar companies
On the latest fiscal year's earnings (2026), Medibank Private's P/E today is 22.8, in line with the median of its last 10 fiscal years (21.7; between 17.2 and 31.4 from 2017 to 2026). Medibank Private's P/E (trailing 12 months): 23.5, +29% against the median of a group of 11 similar companies (18.2).
Compared with 11 similar companies
| Metric | Medibank Private | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 23.5 | High | |
| Forward P/E | 20.0 | High | |
| ROE | 27.2% | High | |
| Price/book | 6.12 | High |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Medibank Private. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
$4.7B
Latest quarter · Q2 2026
Net income
$335.8M
Latest quarter · Q2 2026
Quarterly net margin
7.1%
Latest quarter · Q2 2026
Numbers and valuation
Full valuation- Market cap
- $14.87B
- P/E
- 23.5
- EPS
- $0.23
- Volume
- 6.32M
- Daily trading
- €25M
- Dividend yield
- 3.64%
- Last ex-dividend on September 2, 2026
How Medibank Private is changing
All resultsRevenue grew 5.7% a year on average over the last 5 years
Revenue has grown for 8 fiscal years in a row
Returns
Medibank Private returns with dividends
$1,000 invested in Medibank Private 5 years ago, on November 18, 2021, would be worth $1,849 today with dividends reinvested: +84.85% in total, +13.08% per year. On price alone it would be $1,504 (+50.43%).
| Period | Medibank Private | S&P/ASX 200 | $1,000 becomes |
|---|---|---|---|
| 1 month | +11.16% | +0.42% | $1,112 |
| 6 months | +12.58% | +4.44% | $1,126 |
| Year to date | +10.23% | +1.94% | $1,102 |
| 1 year | +14.45% | +4.89% | $1,144 |
| 3 years | +69.75% | +25.85% | $1,698 |
| 5 years | +84.85% | +20.38% | $1,849 |
| 10 years | +223.05% | +65.75% | $3,231 |
Over the last 6 months it has done better than 65% of the stocks in the Finance sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. S&P/ASX 200: price only. Calculate your investment
The chart in detail
Medibank Private: technical analysis
Medibank Private is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 3.5% below its all-time closing high ($5.47, November 12, 2026).
- Trend
- Upward
- RSI (14 sessions)
- 61
- Between 30 and 70
- vs 200-session average
- +10.96%
Active signals
Golden cross: the 50-session average has crossed above the 200-session average.
since November 5, 2026
Support and resistance
Price areas where Medibank Private has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance$5.31+0.47%2 touches, last on August 7, 2026
- Last price$5.28
- Support$5.04−4.55%2 touches, last on June 29, 2026
- Support$4.85−8.09%7 touches, last on July 6, 2026
- Support$4.73−10.38%5 touches, last on September 16, 2026
Volatility and risk
Over the last year it has moved little with the S&P/ASX 200.
- Beta (1 year) vs S&P/ASX 200
- 0.22
- Volatility (60 sessions, annualised)
- 19.4%
- Largest fall in the last year
- −15.64%
In session, November 18, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Medibank Private: seasonality
Average monthly price change over 12 years
Over the last 12 years, the strongest month for Medibank Private has been April: +3.22% on average, positive in 10 years out of 12. The weakest has been September: −4.47% on average, positive in 2 years out of 12. November, the current month, has been positive in 7 years out of 11 (+0.76% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +0.99% | −0.79% | 5 of 12 |
| February | +1.26% | +1.66% | 7 of 12 |
| March | −0.46% | −0.23% | 5 of 12 |
| April | +3.22% | +3.76% | 10 of 12 |
| May | +2.21% | +1.77% | 9 of 12 |
| June | +0.68% | +0.95% | 8 of 12 |
| July | +2.55% | +4.00% | 9 of 12 |
| August | +1.43% | +0.42% | 6 of 12 |
| September | −4.47% | −5.47% | 2 of 12 |
| October | −0.73% | −0.44% | 5 of 12 |
| November | +0.76% | +0.87% | 7 of 11 |
| December | +1.86% | +0.76% | 8 of 12 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Medibank Private and its competitors
Based in Docklands, Australia, Medibank Private Limited has existed since 1976 and sells health insurance to residents and non-residents in its home market. Its Health Insurance segment offers hospital cover and ancillary cover for dental, optical and physiotherapy care, and extends policies to overseas visitors and students. Under the Medibank and ahm brands, it also runs a Medibank Health segment that provides home care, health management and telehealth, and distributes travel, life and pet insurance, serving government and corporate clients as well as individuals.
- Headquarters
- Docklands, Australia
- Employees
- 5,001
- Founded
- 1976
- Chief executive
- David Koczkar
| Company | Market cap | ROE | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Medibank PrivateMPL | $10.02B | 27.2% | 23.5 | +12.58% |
| Nib HoldingsNHF | $2.28B | 16.4% | 18.7 | +2.54% |
| Helia GroupHLI | $898.94M | 22.1% | 6.46 | −3.84% |
| Japan Post Insurance7181 | $11.17B | 4.2% | 10.7 | +22.51% |
| China Taiping Insurance Holdings0966 | $8B | 28.9% | 1.93 | −19.23% |
| HDFC Life InsuranceHDFCLIFE | $13.16B | 11.3% | 60.0 | −2.24% |
Same industry or related industries, similar size. Compare Medibank Private with its competitors · Full profile
